XYTOS Announces the Appointment of John Trotter II, MD as the Company's New Chief Medical Officer

XYTOS Announces the Appointment of John Trotter II, MD as the Company's New Chief Medical Officer

CARSON CITY, Nev.--(BUSINESS WIRE)--May 26, 2010 - XYTOS, Inc. (the "Company") (OTC: XYTS) is pleased to announce the appointment of John Trotter II, MD as the Company's New Chief Medical Officer. After the company experienced a set back with the unexpected loss of the Company's previous Chief Medical Officer, XYTOS conducted an extensive search over the past two plus years in an effort to find the right person to head up the future of the company's Advanced Medical Technologies.

Dr. Trotter practices General Surgery as well as Family Practice and holds a Medical Degree from George Washington University School of Medicine, Washington, DC and a Bachelor of Science Degree in Biology from Howard University with Honors, (Summa Cum Laude).

Dr. Trotter has conducted multiple research projects with the NATIONAL INSTITUTE OF HEALTH and was selected to assist with NIH research projects at Federal University in Brazil, the Division of Surgical Research & Gene Therapy Center in Lausanne, Switzerland, and the University of Madrid in Spain, to name a few.

Dr. Trotter was elected by Congress to the Physicians' Council for Responsible Health Care, with duties to advise members of Congress on Health Care Reform. He is a member of several Professional Societies including the American College of Surgeons and the American Medical Association.

Dr. Trotter is licensed to practice in multiple States. He has a Strong Administration Background and he as a Network of Private Practice Locations that are managed by his staff. These existing locations will allow XYTOS to quickly introduce our Advanced Medical Procedures to patients.

Tim Cook, Chairman and CEO of XYTOS, Inc., commented, "we are truly excited to have Dr. Trotter as the Chief Medical Officer for the company. He is well versed in the protocols and procedures that XYTOS uses in our Advanced Medical Techniques. He brings to the company access to a network of forward thinking Doctors and global contacts. Dr. Trotter will Train and Oversee the XYTOS Medical Staff as we introduce our Advanced Medical Techniques Globally. We have not made an announcement for a long period of time so this is a significant step towards getting the company back on track."

Dr. John Trotter II M.D., commented, "it is truly exciting to be part of the Advanced Medical Procedures that XYTOS will offer to patients around the World. I look forward to introducing the XYTOS Procedures to Physicians Globally as XYTOS expands its presence."

XYTOS, working at the forefront of the "Science of Medicine," is a Bio-Medical Technologies Company concentrating on the research, development, and introduction of Next Generation Medicine and Medical Procedures in the areas of Stem Cell Therapies, Tissue Engineering, Cellular Medicine, and Cancer.

 

 

Contact: On behalf of the Board of Directors of: XYTOS Inc.
Tim Cook, CEO
(Contact: [email protected])
Telephone: 702-421-5206

 

Suggested Articles

The NIH is starting with Eli Lilly and AbCellera's COVID-19 antibody but could add more prospects as the trial goes on.

The series B positions ex-AveXis executives to build a biotech with a broad gene therapy pipeline and infrastructure to match.

A variant of the ACE2 receptor could work as a COVID-19 therapeutic by drawing the virus away from healthy cells, scientists reported.